The article analyzes the dynamics of lipid peroxidation (LPO) and activity of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase) in erythrocytes of albino rats in experimental diabetes mellitus type 2 induced by five-time administration of streptozotocin (40 mg / kg body weight) and use of plant drugs containing quercetin flavonoids (50 mg / kg body weight daily for 30 days) as a correction factor. Diabetic condition in animals was monitored by way of determining the concentration of glucose in blood plasma and glycosylated hemoglobin level. In the course of investigations it had been established that administration of streptozotocin causes a twofold increase in glucose concentration in blood plasma of rats in the group D1 and glycated hemoglobin (HbA1c) – by 71.6 % at the 90th day of the experiment.

Changes in the identified indicator constants of diabetic condition give evidence of developing diabetes mellitus in experimental animals resulting from the cytotoxic effect of streptozotocin on pancreatic β-cells. Findings of the investigation of glucose concentration in plasma and HbA1c in blood of rats in the group D2 treated with quercetin on experimental streptozotocin diabetes background suggest that the indicated figures remain higher as compared to the control, but significantly decrease in comparison with the figures of animals with simulated streptozotocin diabetes. It has been established that the development of streptozotocin-induced diabetes is accompanied by accumulation of lipid peroxidation products (malondialdehyde), inhibition of superoxide dismutase, glutathione peroxidase in erythrocytes of rats. It has been shown that administration of quercetin under conditions of experimental diabetes reduces the severity of oxidative stress and normalizes the concentration of MDA in the red blood cells due to the stimulating effect on the activity of antioxidant enzymes (superoxide dismutase, glutathione), and improves glycemic status of the animals. These results testify that under the conditions of simulated streptozotocin diabetes red blood cells of white rats develop oxidative stress due to the activation of lipid peroxidation process and inhibition of enzyme activity of the antioxidant system. Plant flavonol quercetin can reduce oxidative stress due to the stimulating effect on the activity of antioxidant enzyme (superoxide dismutase, glutathione reductase) and inhibition of lipid peroxidation in red blood cells of animals. Introduction of quercetin against the background of streptozotocin diabetes causes a decrease in the concentration of glucose in the blood plasma and the level of glycated hemoglobin in the blood of rats in comparison with indicators peculiar to animals with streptozotocin diabetes. Results of our studies complement the existing data on the favorable effect of quercetin on erythrogenesis system cells and demonstrate the capacity of this flavonol to strengthen adaptive response in erythroid cells in response to glycemia caused by oxidative stress. Metabolic effects of quercetin indicate the appropriateness of quercetin for the correction of metabolic changes in erythroid cells, caused by diabetes mellitus type 2.

Added: 16.11.2016

Keywords: diabetic nephropathy, Еxperimental diabetes mellitus type 2, red blood cells in rats, quercetin

Full text: PDF (Ukr) 1.39M

1. 1. Dubinina E, Salnikova L, Efimova L. Activity and isoenzyme spectrum of superoxide dismutase and erythrocyte human blood plasma. Lab. delo. 1983;(10):30-33.
2. 2. Kozlowskaya L, Nikolajev A. Uchebnoye posobiye po klinicheskim laboratornym metodam issledovaniya. Moscow: Medicine; 1984. 288.
3. 3. Korolyuk M, Ivanova L, Mayorova I, Tokarev V. The method for determining the activity of catalase. Lab. delo. 1983;(10):16-18.
4. 4. Moin V. A simple and specific method for determining the activity of glutathione peroxidase in erythrocytes. Lab. delo.1986;(12):724-727.
5. 5. Abarikwu S, Pant A, Farombi E. Dietary antioxidant, quercetin, protects sertoli-germ cell coculture from atrazine-induced oxidative damage. J. Biochem. Mol. Toxicol. 2012;26(11):477-485. doi.org/10.1002/jbt.21449
6. 6. Baskurt O, Meiselman H. Erythrocyte aggregation: basic aspects and clinical importance. Clin. Hemorheol. Microcirc. 2013;53(1-2):23-37.
7. 7. Boots A, Haenen G, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008;585(2-3):325-337. doi.org/10.1016/j.ejphar.2008.03.008
8. 8. Buys A, Van Rooy M, Soma P, Van Papendorp D, Lipinski B, Pretorius E. Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc. Diabetol. 2013;12:25. doi.org/10.1186/1475-2840-12-25
9. 9. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 1975;250:5475-5480.
10. 10. Gonzalez-Gallego J, Garcia-Mediavilla M, Sanchez-Campos S, Tunon MJ. Fruit polyphenols, immunity and inflammation. Br. J. Nutr. 2011;104(3):S15-S27.
11. 11. Kakkar R, Kalra J, Mantha S, Prasad K. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol. Cell. Biochem. 1995;151(2):113-119. doi.org/10.1007/BF01322333
12. 12. Kaymaz A, Tamer S, Albeniz I, Cefle K, Palanduz S et al. Alterations in rheological properties and erythrocyte membrane proteins in cats with diabetes mellitus. Clin. Hemorheol. Microcirc. 2005;33(2):81-88.
13. 13. Kobori M, Masumoto S, Akimoto Y, Takahashi Y. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res. 2009;53(7):859-868. doi.org/10.1002/mnfr.200800310
14. 14. Kung C, Tseng Z, Wang H. Erythrocyte fragility increases with level of glycosylated hemoglobin in type 2 diabetic patients. Clin. Hemorheol. Microcirc. 2009;43(4):345-351.
15. 15. Lowry O, Rosenbrough N, Farr A. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265-275.
16. 16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979;95:351-358. doi.org/10.1016/0003-2697(79)90738-3
17. 17. Parker K, England J, Da Costa J, Hess R, Goldstein D. Improved colorimetric assay for glycosylated hemoglobin. Clin. Chem. 1981;27(5):669-672.
18. 18. Presnell C, Bhatti G, Numan L, Lerche M, Alkhateeb S et al. Computational insights into the role of glutathione in oxidative stress. Curr. Neurovasc. Res. 2013;10(2):185-194. doi.org/10.2174/1567202611310020011
19. 19. Pu L, Shen Y, Lu L, Zhang R, Zhang Q, Shen W. Increased blood glycohemoglobin A1c levels lead to overestimation of arterial oxygen saturation by pulse oximetry in patients with type 2 diabetes. Cardiovasc. Diabetol. 2012;11:110. doi.org/10.1186/1475-2840-11-110
20. 20. Robertson R, Zhou H, Zhang T, Harmon J. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell. Biochem. Biophys. 2007;48(2-3):139-146. doi.org/10.1007/s12013-007-0026-5
21. 21. Sena C, Bento C, Pereira P, Seiça R. Diabetes mellitus: new challenges and innovative therapies. EPMA J. 2010;1(1):138-163. doi.org/10.1007/s13167-010-0010-9
22. 22. Sivilotti M. Oxidant stress and haemolysis of the human erythrocyte. Toxicol. Rev. 2004;23:169-188. doi.org/10.2165/00139709-200423030-00004
23. 23. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J. Med. Res. 2007;125:451-472.
24. 24. Tipikin I, Rozhkova E, Seĭfulla R, Ordzhonikidze Z, Paniushkin V. Flavonoid correction of functional elasticity of erythrocyte membranes and hemorheological disorders during oxidative stress caused by chronic physical overstrain in mice. Eksp. Klin. Farmakol. 2011;74(10):26-30.
25. 25. Vega-López S, Devaraj S, Jialal I. Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J. Investig. Med. 2004;52(1):24-32. doi.org/10.1136/jim-52-01-23
26. 26. Yamagishi S, Matsui T. Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy. Curr. Pharm. Biotechnol. 2011;12(3):362-368. doi.org/10.2174/138920111794480534
27. 27. Yang H, Jin X, Kei Lam CW, Yan SK. Oxidative stress and diabetes mellitus. Clin. Chem. Lab. Med. 2011;49(11):1773-1782. doi.org/10.1515/cclm.2011.250
28. 28. Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvish L. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int. J. Prev. Med. 2013;4(7):777-785.